China Money Network
Login
Join

Chinese Biotech Firm Immunochina Raises $20M In Series C Round

  • January 24, 2019 — 10:19 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese biotechnology company Immunochina Pharmaceuticals has raised a RMB$140 million (US$20.4 million) series C round of financing led by a syndicate of Chinese and international... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: